Eruption of lymphocyte recovery or autologous graft-versus-host disease?
Maculopapular exanthemas have a particular high incidence among patients treated with autologous hematopoietic stem cell transplantation (HSCT). In most cases, a viral or drug induced origin is easily identified. However, the transplantation itself may also induce similar skin changes. These exanthemas are known under various names, such as autologous graft-versus-host disease (GVHD), engraftment syndrome (ES) or eruption of lymphocyte recovery (ELR). Given the clinical and histopathological similarities of these disorders, it can prove difficult to establish a diagnosis. Here, we describe a patient who developed a maculopapular exanthema after autologous stem cell transplantation for multiple myeloma, diagnosed as autologous GVHD. We also briefly review the current knowledge of the pathogenesis of autologous GVHD, ES, and ELR. Based on these data we would like to suggest that the latter two do not reflect own disease entities but rather different presentations of autologous GVHD.
Nellen
Ruud G L
RG
Department of Dermatology, Maastricht University Medical Center, The Netherlands. rnel@sder.azm.nl
van Marion
Arienne M W
AM
Frank
Jorge
J
Poblete-Gutiérrez
Pamela
P
Steijlen
Peter M
PM
D001706:Biopsy; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000209:etiology* / Q000276:immunology / Q000473:pathology